The maternal lifestyle study: Cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age

Pediatrics

Volumn 113, Issue 6 I, 2004, Pages 1677-1685

  Messinger, Daniel S ^a,j   Bauer, Charles R ^b   Das, Abhik ^c   Seifer, Ron ^d   Lester, Barry M ^d   Lagasse, Linda L ^d   Wright, Linda L ^e   Shankaran, Seetha ^f   Bada, Henrietta S ^g   Smeriglio, Vincent L ^h   Langer, John C ^c   Beeghly, Marjorie ⁱ   Poole, W Kenneth ^c  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^h NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j Psychology Annex   (United States)

more..

Author keywords

BSID II; Cocaine; Opiates; Outcome; Prenatal exposure

Indexed keywords

COCAINE; ILLICIT DRUG; OPIATE;

ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR; BIRTH WEIGHT; CAREGIVER; CHILD CARE; CHILD DEVELOPMENT; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EVALUATION; FEMALE; HUMAN; INFANT; LIFESTYLE; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL BEHAVIOR; MENTAL DEVELOPMENT; MENTAL DISEASE; MOTOR DEVELOPMENT; MULTICENTER STUDY; OPIATE ADDICTION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR DEVELOPMENT; RATING SCALE;

CHILD BEHAVIOR; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COCAINE; FEMALE; HUMANS; INFANT; INTELLIGENCE; LINEAR MODELS; LONGITUDINAL STUDIES; MOTOR SKILLS; NARCOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 2542515460     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.6.1677     Document Type: Article

References (50)

1. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol. 2003;101:374-379
2. National Institute on Drug Abuse. National Pregnancy and Health Survey. Rockville, MD: National Institutes of Health; 1996 (93-3819)
3. Substance Abuse and Mental Health Services Administration. Summary of Findings From the 2000 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies; 2001
4. Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics. 1993;92:396-402
5. Hulse GK, English DR, Milne E, Holman CDJ, Bower CI. Maternal cocaine use and low birth weight newborns: a meta-analysis. Addiction. 1997;92:1561-1570
6. Brown JV, Bakeman R, Coles CD, Sexson WR, Demi AS. Maternal drug use during pregnancy: are preterm and full-term infants affected differently? Dev Psychol. 1998;34:540-554
7. Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyles Study (MLS): the effects of substance exposure during pregnancy on acute maternal outcomes. Pediatr Res. 1996;39:257A
8. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: the meaning of subtle effects. Science. 1998;282:633-634
9. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA. 2001;285:1613-1625
10. Bayley N. Manual for the Bayley Scales of Infant Development. San Antonio, TX: The Psychological Corporation; 1969
11. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: The Psychological Corporation; 1993
12. Singer L, Arendt R, Farkas K, Minnes S, Huang J, Yamashita T. Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome. Dev Psychopathol. 1997;9:473-489
13. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Chiodo LM. New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatr. 1996;129:581-590
14. Fetters L, Tronick EZ. Neuromotor development of cocaine exposed and control infants from birth to 15 months. Pediatrics. 1996;98:938-943
15. Arendt R, Angelopoulos J, Salvator A, Singer L. Motor development of cocaine-exposed children at age two years. Pediatrics. 1999;103:86-92
16. Singer LT, Arendt R, Minnes S, et al. Cognitive and motor outcomes of cocaine-exposed infants. JAMA. 2002;287:1952-1960
17. Arendt R, Singer L, Angelopolous R, Bass-Busdiecker O, Mascia J. Sensorimotor development in cocaine-exposed infants. Infant Behav Dev. 1998;21:627-640
18. Chasnoff IJ, Griffith DR, Freier C, Murray J. Cocaine/polydrug use in pregnancy: two-year follow up. Pediatrics. 1992;89:284-289
19. Alessandri SM, Bendersky M, Lewis M. Cognitive functioning in 8- to 18-month-old drug-exposed infants. Dev Psychol. 1998;92:565-573
20. Frank DA, Jacobs RR, Beeghly M, et al. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight. Pediatrics. 2002;110:1143-1152
21. Hurt H, Brodsky NL, Betancourt L, Braitman LE, Malmud E, Giannetta J. Cocaine-exposed children: follow-up through 30 months. Dev Behav Pediatr. 1995;16:29-35
22. Hans SL, Jeremy RJ. Postneonatal mental and motor development of infants exposed in utero to opioid drugs. Infant Ment Health J. 2001;22:300-315
23. Johnson HL, Angela D, Rosen TS. 24 month neurobehavioral follow-up of children of methadone-maintained mothers. Annu Prog Child Psychiatry Child Dev. 1985:11-20
24. Schneider JW, Hans SL. Effects of prenatal exposure to opioids on focused attention in toddlers during free play. J Dev Behav Pediatr. 1996;17:240-247
25. LaGasse L, Lester B, Seifer R. Interpreting research on prenatal substance exposure in the context of multiple confounding factors. Clin Perinatol. 1999;26:39-54
26. Bauer C, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol. 2002;186:487-495
27. Lester BM, Tronick EZ, LaGasse L, et al. The Maternal Lifestyle Study (MLS): effects of substance exposure during pregnancy on neurodevelopmental outcome in one-month old infants. Pediatrics. 2002;110:1182-1192
28. Lester BM, ElSohly M, Wright L, et al. The Maternal Lifestyles Study (MLS): drug use by meconium toxicology and maternal self-report. Pediatrics. 2001;107:309-317
29. LaGasse L, Seifer R, Wright L, et al. The Maternal Lifestyle Study (MLS): the caretaking environment of infants exposed to cocaine/opiates. Pediatr Res. 1999;45:247A
30. US Census Bureau. Current Population Survey Poverty Thresholds. Available at: www.census.gov/hhes/poverty/threshld.html
31. Caldwell B, Bradley R. Home Observation for Measurement of the Environment (HOME) Inventory. Little Rock, AR: University of Arkansas at Little Rock;1984
32. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test-Revised. Circle Pines, MN: American Guidance Service; 1981
33. Derogatis LR. Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. 3rd ed. Minneapolis, MN: National Computer Systems; 1993
34. Ballard KL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417-423
35. Bryk AS, Raudenbush SW. Hierarchical Linear Models: Applications and Data Analysis Methods. London, UK: Sage; 1992
36. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163-168
37. Mayes LC, Fahy T. Prenatal drug exposure and cognitive development. In: Sternberg RJ, Grigorenko EL (eds). Environmental Effects on Cognitive Abilities. Mahwah, NJ: Lawrence Erlbaum Associates; 2001:189-219
38. Kilbride H, Castor C, Hoffman E, Fuger KL. Thirty-six month outcome of prenatal cocaine exposure for term or near-term infants: impact of early case management. J Dev Behav Pediatr. 2000;21:19-26
39. Jacobson JL, Jacobson SW. Strategies for detecting the effects of prenatal drug exposure: lessons from research on alcohol. In: Lewis M, Bendersky M (eds). Mothers, Babies, and Cocaine: The Role of Toxins in Development. 1st ed. Hillsdale, NJ: Lawrence, Erlbaum Associates; 1995:111-128
40. Lester BM, Tronick EZ. The effects of prenatal cocaine exposure and child outcome. Infant Ment Health J. 1994;15:107-120
41. Lester BM, Corwin MJ, Sepkoski C, Seifer R, et al. Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Dev. 1991;62:694-705
42. Bada H, Bauer CR, Shankaran S, et al. Central and autonomic system signs with in utero drug exposure. Arch Dis Child Fetal Neonatal Ed. 2002;87:F106-F112
43. Mayes LC, Granger RH, Frank MA, Schottenfeld R, Bornstein MH. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics. 1993;91:778-783
44. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics. 1998;101:237-241
45. Eisen LN, Field TM, Bandstra ES, et al. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics. 1991;88:477-480
46. Singer LT, Arendt RM, Minnes S, Farkas K, Salvator A. Neurobehavioral outcomes of cocaine-exposed infants. Neurotoxicol Teratol. 2000;22:653-666
47. Mayes LC, Bornstein MH, Chawarska K, Granger RH. Information processing and development assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics. 1995;95:539-545
48. Alessandri SM, Sullivan MW, Imaizumi S, Lewis M. Learning and emotional responsivity in cocaine-exposed infants. Dev Psychol. 1993;29:989-997
49. Singer LT, Arendt R, Minnes S, Salvator A, Siegel AC, Lewis BA. Developing language skills of cocaine-exposed infants. Pediatrics. 2001;107:1057-1064
50. Delaney-Black V, Covington C, Templin T, Ager J, Martier S, Sokol R. Prenatal cocaine exposure and child behavior. Pediatrics. 1998;102:945-950